Inspiring young scientists

We're exciting young minds with the real world possibilities of science.

Patients & consumers

Don’t forget the pharmacists

How we do business

Switching on to consumer choice: Medicines for everyday health

How our consumer strategy is improving quality of life and access to established medicines through innovation

Access to healthcare

Rabies – Educate, Vaccinate, Eliminate.

28 September is World Rabies Day, when organisations across the globe, all with the common goal of eliminating human deaths from rabies by 2030, work together to raise awareness of this ‘neglected tropical disease’ under the theme ‘Educate, Vaccinate, Eliminate’.

Our people

Partnership for Prevention

Anthony Tropea has been part of the team leading the roll-out of our Partnership for Prevention Programme.

How we do business

Collaboration: unlocking a new approach to clinical trials

Innovation

Scientists or detectives? Seeking new clues in COPD

How we do business

Helping to change the world

Access to healthcare

A new response to humanitarian crises

Humanitarian crises are becoming more frequent, more widespread and more complex. It’s clear that a new approach is needed.

Our people

A partnership that is all about the chemistry

See how our GSK trainer train sub Saharan Africa scientists in analytical chemistry.

Innovation

Can an iPhone transform the way we monitor and improve patient health?

GSK is using digital technologies and channels to improve the efficiency of our research, and to improve patient care.

Access to healthcare

The app that could save lives

How our partnership with Save the Children is boosting healthcare innovation that supports vulnerable children.

Our people

Changing gears in a scientific career

Our people

Engineering a successful career

Innovation

Inhaler innovation: more than a simple piece of plastic

Most of us will know someone who suffers from asthma and uses an inhaler regularly to control their condition.

Innovation

From microscope to telescope and beyond – exploring with NASA's CASIS

Medical research relies on curious scientists to peer into cells through microscopes and to think on a molecular.

Access to healthcare

Meet Baby Mckline: a special delivery from our Save the Children partnership

Mckline is a special little boy. Almost two years old, he lives in Kenya with his parents Catherine and Fredrick. They are already saving for his education and have ambitions for him to be an engineer one day.

Access to healthcare

Pro Mujer: supporting healthier lives in Latin America

Since 2009, we have been working with Pro Mujer, helping women like Rosa lift themselves and their families out of poverty, and giving them access to high-quality, low-cost healthcare, often for the first time.

Our people

From academia to industry: a new challenge

Our people

Andy Dundon: the design behind the device

Patients & consumers

Groundswell: 2016 GSK IMPACT Awards Overall Winner

Groundswell is one of ten charities to win a 2016 GSK IMPACT Award, run in partnership with the King’s Fund.

Patients & consumers

Age UK South Lakeland: 2016 GSK IMPACT Award winner

Age UK South Lakeland is one of ten charities to win a 2016 GSK IMPACT Award, run in partnership with the King’s Fund.

Patients & consumers

Promoting a More Inclusive Society (PAMIS): 2016 GSK IMPACT Award winner

PAMIS is one of ten charities to win a 2016 GSK IMPACT Award, run in partnership with The King’s Fund, run in partnership with the King’s Fund.

Patients & consumers

An 'everyday' world first in clinical trials

The way we design and carry out clinical trials is being turned on its head by the advent of the Salford Lung Study (SLS).

Patients & consumers

Body & Soul: 2016 GSK IMPACT Award winner

Access to healthcare

The 30-year quest for world's first malaria vaccine

Innovation

Turning the tide on antibiotic resistance| New antibiotics

Turning the tide on antibiotic resistance.

Patients & consumers

Does lupus really know no boundaries?

Tuesday 10th May 2016 marks World Lupus Day and patient organisations around the world will be supporting the World Lupus Federation’s ‘Lupus Knows No Boundaries’ campaign.

Our people

Clinical Trials: Q&A with Murray Stewart

Dr. Murray Stewart is our Chief Medical Officer. In this role, he is the most senior physician at GSK, and has overall responsibility for patient well-being across vaccines, pharmaceutical and consumer medicines. He also oversees medical ethics and integrity.

Access to healthcare

Giving mothers and babies a healthier start

Find out how our scientists have adapted an ingredient from a GSK mouthwash into a potentially life-saving gel for newborns in developing countries

Patients & consumers

Living with severe asthma

Our people

Respiratory disease: why we want to make a difference

Our people

Safety first: Employee wellbeing rides on it

Rajendra is a medical representative in India. He commutes 30 kilometres everyday by motorcycle - and that doesn't even include the time spent on the road during the day.

How we do business

The power of partnerships: transforming vaccine coverage in Mozambique

More than 35,000 children in the northern Mozambique province of Nampula are now registered with the mVacciNation pilot programme that was rolled out in 2015 by GSK and Vodafone, with funding from GAVI and USAID.

Innovation

Vaccine manufacture: it’s complicated

Vaccine manufacture can take anywhere between 6 and 26 months.That’s not to mention the time required to research and develop a new vaccine, which can take up to 30 years.

Patients & consumers

A story by numbers - Meningococcal Disease

Meningococcal disease, commonly called meningitis, is a sudden, potentially life-threatening illness.

Patients & consumers

What parents know about meningococcal disease

Our people

Beyond manufacturing in Chile and Madagascar

Our people

Why I #fightmalaria: Laura's story

Laura is a scientist and a mum. Here she describes what motivates her to fight against malaria.

Access to healthcare

The value of vaccination

According to the World Health Organization, only clean drinking water rivals vaccination in its ability to save lives.

Patients & consumers

Creating a win for disease prevention

From April 2016, our global disease awareness campaign Win for Meningitis will see Paralympians from around the world taking part in a photo shoot with renowned photographer Anne Geddes.

Innovation

Playing the innovation game

Besides good timing and even better luck, it’s hard to pinpoint what it takes to be an innovator. Innovators tend to be creative, exceptionally persistent, and prepared to take calculated risks.

Patients & consumers

Win for Meningitis

Patients & consumers

Living with Lupus – a patient perspective

How we do business

Does the relationship between the pharmaceutical industry and healthcare professionals need to change?

We have made a number of changes to how we interact with healthcare professionals (HCPs), including how we incentivise our pharmaceutical sales representatives, how we support medical education and stopping payments to external HCPs to speak on our behalf about our prescription medicines.

Innovation

Take a deep breath – your lung microbiome will appreciate it

Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity.

Patients & consumers

Helping to further science and research – Howard’s perspective

The Salford Lung Study is a ground breaking clinical trial that explores how effective a treatment for COPD is in everyday life.

Innovation

TB or not TB

As recently as 30 years ago, tuberculosis (TB) was believed to be under control.

Innovation

GSK’s Chief Immunology Officer discusses unlocking the secrets of the immune system to tackle disease

Innovation

Bioelectronics at SXSW 2016

How we do business

Helping communities | GSK Impact Awards

The King’s Fund is a charity focused on improving healthcare in the UK. In partnership with GSK, The King’s Fund manages the annual GSK IMPACT Awards.

Patients & consumers

Healthcare challenges: Help for the most vulnerable communities

Healthcare charities tackle some of society’s most difficult and often overlooked challenges.

How we do business

STEM curriculum in school inspires students to become scientists

Dr Louise Morris says she wants every student at her school to have the education and opportunity to have a career in STEM.

Innovation

Future medicine: How will we fight disease in 10 years?

Innovation

Developing biosensors and bioelectronics

How we do business

GSK’s Patrick Vallance on a new generation antibiotics

GSK’s President of Pharmaceutical R&D explains why GSK is involved in challenging antibiotics resistance.

Innovation

Biolectronic medicines: Harnessing body's electrical language

Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.

Access to healthcare

Our humanitarian work: Saving one million children's lives

Patients & consumers

19 years of support: GSK Impact Awards

Our people

Rare Disease Day 2016: What it means to us

Rare Disease Day on 29th February holds personal significance for two colleagues working in our Rare Disease Unit; Jessica Imrie and Julie Venners Christensen both have children with rare disorders.

Innovation

Rare diseases are not that rare

A rare disease affects 1 in 2000 people or fewer.

Innovation

Rare diseases: unscrambling the code

We have a dedicated rare disease unit, with the ultimate goal of developing breakthrough solutions for people affected by rare diseases and delivering much needed medicines.

How we do business

How we are bringing science to life | GSK R&D

Patrick Vallance is something of a rare breed: a game-keeper turned poacher; an academic who's moved over into industry. And not just any industry, but the pharmaceutical industry.

Innovation

Inspiring the next generation of scientists

Access to healthcare

Tackling malaria in the worst affected countries

Patients & consumers

Alzheimer’s Support: 2015 GSK Impact Award winner

Alzheimer’s Support is one of ten charities to win a 2015 GSK IMPACT Award, run in partnership with The King’s Fund.

Patients & consumers

Mental health charity Restore - GSK Impact Awards winner

RESTORE is one of ten charities to win a 2015 GSK IMPACT Award, run in partnership with the King’s Fund.

Patients & consumers

Helping communities | 2015 GSK Impact Award winner

The Junction is one of ten charities to win a 2015 GSK IMPACT Award, run in partnership with the King’s Fund.

Patients & consumers

Neuromuscular Centre: 2015 GSK Impact Award winner

Neuromuscular Centre in Cheshire supports people affected by Muscular Dystrophy to maintain the best quality of life and is one of ten charities to win a 2015 GSK IMPACT Award, run in partnership with the King’s Fund.

Access to healthcare

Developing vaccine against the malaria virus

How we do business

Humanitarian challenges: Child & maternal mortality stats

Patients & consumers

The Global Pain Index: an insight into the world of pain

The impact of body pain on sufferers and the people around them is the focus of a new in-depth study carried out by GSK Consumer Healthcare - the GSK Global Pain Index

Our people

On the job with GSK's medical device research team

A mechanical engineering graduate on a GSK Future Leaders Programme is helping to develop user-friendly devices to administer treatments safely.

Access to healthcare

Science hasn't answered all questions on curing HIV

Dr Kimberly Smith, vice president of medical strategy at ViiV Healthcare, shares her experiences of a career spent working to find a cure for the disease.

Innovation

Igniting a revolution in scientific research and development

Innovative partnerships between science, business and charities could help tackle some of the most challenging healthcare issues, transforming the prospects of developing countries.

Our people

Volunteering in Kenya: a once in a lifetime experience

Our people

Treating malaria: Making a change from the inside

How we do business

Improving maternal health & reducing infant mortality in Kenya | GSK

Find out how we are helping to cut maternal and newborn mortality rates in Kenya.

How we do business

See how GSK supports STEM in the real world

Explore how we invest in the scientists of the future.

Access to healthcare

Benefits of receiving a 'charitable Oscar' | Community charity

Jennifer Fear, CEO of Step Forward, describes how she and her charity benefited from winning a GSK IMPACT Award.

How we do business

Disclosing information on payments to doctors has already had positive effects in Europe

Find out how we will be publicly disclosing information on payments and transfers of value that we make to doctors and other healthcare professionals (HCPs).

Access to healthcare

Guardian article: Finding new ways to give mothers and new-borns a healthier start

Access to healthcare

Malaria: Key facts

Access to healthcare

Statistics and information about malaria

See how malaria still leaves a devastating toll on communities and economies.

How we do business

Turning waste into a resource

We set a target - to achieve ‘zero waste to landfill’ at all our sites by 2020. Already, over 60% of GSK sites and offices have achieved the target.

Our people

Simon Wright, Head of Child Survival at Save the Children gives a partnership perspective

Simon Wright, Head for Child Survival at Save the Children, talks about how we’re working together to make sure the health needs of the world’s poorest children are at the top of everyone’s agenda.

Access to healthcare

Comic Relief and GSK form a partnership to fight malaria

GSK has teamed up with Comic Relief to improve the lives of millions of people in Africa and Asia. Engineer and GSK executive Andy Wright explains.

How we do business

Bloomberg TV: Sir Andrew Witty, CEO, GSK, discusses antibiotic resistance in Davos

How we do business

Save the Children partnership: Key facts & stats

Our people

Intrapreneurship: keeping our fingers on the PULSE

We're encouraging our employees to explore new ideas beyond the remit of their role

Innovation

Turbocharging the effect of vaccines

When extracted and purified, a compound from the soap bark tree can be mixed with other ingredients to create an ‘adjuvant’, turbocharging the body's immune defences.

Patients & consumers

Helping to protect yourself against flu

Influenza, commonly called ‘the flu’, is a contagious infection of the respiratory tract, which affects people of all ages.

Innovation

Experimental medicine

Studies often employ state-of-the art technology to help scientists and doctors track the effect of a potential new medicine in patients’ bodies.

Innovation

Outgrowing asthma

Access to healthcare

TEDMED 2015: An interview with curator, Christine McNab

Patients & consumers

STEM in the real world

At Waldegrave School for Girls in Twickenham there is a drive to enthuse pupils about the possibilities and opportunities that STEM subjects can offer.

Access to healthcare

TEDMED 2015: Art, inspired by vaccination

A blank canvas, Unformed clay. An empty petri dish.

Patients & consumers

Living every day with COPD: José’s story

Simple activities are an everyday struggle for people living with COPD. José gives his perspective on the impact that COPD has on him.

Our people

War and peace: Ivo, Nobel prize winner

In the world of business—and scientific research—war metaphors abound. “Hitting our targets.” “Fighting cancer.” What we don’t see are many comparisons to peacekeeping.

Our people

Changing Lives

Our people

Formal STEM education not necessary for career in science

Access to healthcare

Reducing child & maternal death rates in Kenya

Angela Muriuki finds that combating the high death rates in mothers and newborns in parts of Kenya involves knowledge of the culture of the people involved and the practical problems they face accessing healthcare.

Our people

Rare diseases: Q&A with Martin Andrews

Martin Andrews leads our efforts to advance the treatment of rare diseases.

How we do business

Less is more with advanced technologies in manufacturing

Is ‘continuous manufacturing’ the best way to be greener?

How we do business

Using biology to increase quality and reduce carbon footprint

We've introduced new manufacturing technologies that will help deliver greater numbers of higher quality medicines more effectively to patients.

Access to healthcare

Five years. 40,000 health workers. 11 million people.

Access to healthcare

The fight against malaria

Innovation

The science behind sport

The state-of-the-art facility where scientists are using cutting-edge technology to examine body and brain function.

Innovation

Targeting the immune system through open innovation

A functioning immune system is crucial to our health. We have discovered that its role goes beyond such things as keeping colds at bay & fighting infections.

Access to healthcare

Causes & prevention of malaria: fighting it on the frontline

Almost everyone in Tanzania is at risk of malaria. The mosquito-borne disease is responsible for more than 10% of deaths among children under five in this East African country.

Access to healthcare

Malaria in Africa: No 'silver bullet' to tackle it

The combination of increased funding, resources and education to fight malaria have contributed to a reduction in deaths from this mosquito-borne disease.

Access to healthcare

On the frontline of Ebola prevention

Access to healthcare

Ebola: our fast track response

Innovation

Keeping ahead of the game

To be the best at what we do, we rely on innovative science to create products capable of transforming the lives of patients.

Innovation

Fluorescent bacteria - nowhere to hide

Learn how a new approach known as “bacteria-instructed synthesis” helps tackle bacterial infection.

Access to healthcare

Making our vaccines more accessible

We are determined to use our resources, knowledge and expertise to help improve access to immunisation.

Our people

How we innovate to save children in Africa | GSK charity

Lisa Bonadonna, head of the partnership at GSK, talks about a product innovation under development.

Access to healthcare

Vaccines - coming in from the cold

Patients & consumers

Every breath you take: Alison’s story

Access to healthcare

Motivating a global coalition

GSK’s Jon Pender explains why working in partnership was key to addressing the pace of the Ebola outbreak in 2014.

Innovation

Cell and gene therapy: a new era of medicine

If we can pinpoint a faulty gene and correct it, could we potentially find a way to cure genetic diseases?

Access to healthcare

Fighting Ebola highlights the need for more health workers

The Ebola crisis of the past 14 months is by far the worst outbreak of the disease the world has ever seen.

Innovation

Enriching our clinical trials data

Finding new ways to use biosensors and mobile health platforms to improve patient care.

How we do business

Why our transaction with Novartis is different

Access to healthcare

Ebola vaccine R&D

Access to healthcare

Forming public partnerships

The Ebola crisis has been an unusual and rapidly changing situation. Find out how we are responding.

Access to healthcare

Our humanitarian response response to the Ebola outbreak

GSK's on-going efforts to strengthen healthcare infrastructure in the most affected countries.

Access to healthcare

Malaria: life cycle of a parasite

Find out more about malaria and the life cycle of the parasites that cause it.

Our people

A healthier future for Africa

Our VP of east Africa and government affairs, Allan Pamba, explains his desire to improve the health of people in Africa.

Our people

Females in science: The story of a GSK apprentice

Our people

Employee volunteering gets personal

Access to healthcare

The critical workers boosting children’s health

As a community health worker in Liberia – communities rely on people like Christopher for essential healthcare.

How we do business

Changing the way we work with healthcare professionals

Putting patients’ interests at the heart of every decision.

Innovation

Understanding human performance

Explore state-of-the-art facilities where scientists use cutting-edge technology to examine body and brain function.

How we do business

Flonase: the journey from prescription to OTC

Switching a product from a prescription medicine to over the counter (OTC) is nothing to sniff at.

Access to healthcare

Africa’s fight against malaria: how mothers are helping on the ground

How we do business

How we evaluate our investment options

How we do business

Increasing access in India

Reaching hard-to-reach villages which currently represent 70% of India’s 1.2 billion population.

Our people

From academia to industry

Patrick Vallance talks about how he went from leading an academic department to his current role heading up our R&D operations.

Our people

From student digs to Buckingham Palace

Danielle Smith is on the Communications Graduate programme and joined GSK in 2012 after graduating from the University of York.

Access to healthcare

Helping women to give birth safely

Helping midwives like Mary develop their skills and ensure more women give birth safely in Africa.

How we do business

Inhaler recycling

Patients & consumers

Science of a different stripe

Innovation

Bacteria: friends or foes?

What if instead of trying to see off the bugs, we harnessed them and made them work for us, instead of against us?

How we do business

'Rightsizing' our tablet packaging to reduce carbon emissions

How can you fit six tablets into the same space as four – and why would you want to?

Innovation

Can mosquitoes prevent malaria?

Find out how we are breeding 2,000 mosquitoes every week in the search for anti-malarial medicines.

Patients & consumers

Eggs in manufacturing

Chickens. Where would we be without them? Well for one thing, we wouldn’t have nearly as many influenza vaccines as we need.

Innovation

Data transparency

Patients & consumers

Novamin - the accidental curist

Innovation

Inside the Open Lab

Learn how the Tres Cantos Open Lab offers top international scientists and academics the opportunity to pursue their own projects as part of an integrated team.

Our people

Meet Alicia - a graduate engineer

Alicia joined our graduate scheme as an electrical engineer in September 2012.

Innovation

Neuroscience: on the brain

The number of people living with dementia worldwide is set to treble by 2050 to 135 million, according to the World Health Organization.

Innovation

Healthcare in your pocket

From SMS to asthma apps. Mobile internet has changed the way we live and work.

Access to healthcare

The 'baby bubble'

How we do business

Green chemistry

Access to healthcare

Algueta's smile: fighting lymphatic filariasis

Tijana Duric looks after the supply planning for albendazole in our neglected tropical diseases unit.

Access to healthcare

Life after polio: Fatiha's story

Fatiha describes her experience of polio and why she wanted to work for GSK.

Back to top